Position in REGN
as of Jun 30, 2026
· filed Jul 6, 2026
Position Value
$196,415
-$121,912 QoQ
Shares Held
315
-23.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#166
of 236 holders
Holding Since
Dec 2021
17 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CoreCap Advisors, LLC holds $2,312,000 across 78 Biotechnology names. REGN ranks #5 (8.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
6,755 | $367,539 | |
| 2 | MRNA |
Moderna, Inc.
|
4,595 | $321,787 | |
| 3 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
3,000 | $244,530 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
442 | $219,554 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
315 | $196,415 | |
| 6 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
280 | $150,346 | |
| 7 | ANIX |
Anixa Biosciences Inc
|
52,020 | $145,656 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
428 | $135,286 |
All Filings in REGN
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $196,415 | 315 | Shares | Sole | 2026-07-06 | |
| 2026-03-31 | $318,327 | 412 | Shares | Sole | 2026-04-07 | |
| 2025-12-31 | $613,636 | 795 | Shares | Sole | 2026-01-13 | |
| 2025-09-30 | $133,820 | 238 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $114,450 | 218 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $150,312 | 237 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $189,479 | 266 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,079,081 | 2,929 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $328,972 | 313 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $375,371 | 390 | Shares | Sole | 2024-08-08 | |
| 2023-12-31 | $1,461,474 | 1,664 | Shares | Sole | 2024-01-16 | |
| 2023-09-30 | $207,385 | 252 | Shares | Sole | 2024-01-16 | |
| 2023-06-30 | $202,628 | 282 | Shares | Sole | 2024-01-16 | |
| 2022-12-31 | $420,628 | 583 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $255,570 | 371 | Shares | Sole | 2023-02-10 | |
| 2022-06-30 | $1,525,115 | 2,580 | Shares | Sole | 2022-08-11 | |
| 2021-12-31 | $144,618 | 229 | Shares | Sole | 2022-02-10 | |
| No filing history on record for this holder in this stock. | ||||||